Srovnání nových antipsychotik (lurasidonu, kariprazinu a brexpiprazolu) z klinického úhlu pohledu
| Title in English | Comparison of new antipsychotics (lurasidone, cariprazine and brexpiprazole) from the clinical point of view |
|---|---|
| Authors | |
| Year of publication | 2021 |
| Type | Article in Periodical |
| Magazine / Source | Psychiatrie pro praxi |
| MU Faculty or unit | |
| Citation | |
| Web | https://www.solen.cz/artkey/psy-202102-0004_srovnani_novych_antipsychotik_lurasidonu_kariprazinu_a_brexpiprazolu_z_klinickeho_uhlu_pohledu.php?back=%2Fsearch.php%3Fquery%3DREUMATOIDN%2525ED%252520ARTRIT%2525EDDA%26sfrom%3D60%26spage%3D30 |
| Keywords | brexpiprazole; cariprazine; lurasidone; efficacy; side effects; schizophrenia |
| Description | Three new antipsychotics - cariprazine, lurasidone and brexpiprazole - have been introduced to the Czech market in the past two years. This review article aims to compare them from a clinical point of view. It focuses on their basic characteristics including receptors profile, indications and efficacy, dosage including dose-response relationship and, last but not least, on their tolerability and side effects. |